Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Cash from Investing Activities (2010 - 2026)

Repligen's (RGEN) quarterly Cash from Investing Activities came in at -$2.1 million in Q2 2026, up 73.35% year-over-year from -$1.2 million in Q2 2025, and up 47.62% quarter-over-quarter from -$4.0 million in Q1 2026.

Analysis

Repligen (RGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Repligen (RGEN) has reported Cash from Investing Activities for 17 consecutive years, with -$2.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities rose 73.35% year-over-year to -$2.1 million in Q2 2026; TTM through Jun 2026 was -$222.6 million, a 45.9% decrease from a year earlier, with the FY2025 full-year figure at -$298.5 million, down 245.52% from the prior year.
  • Cash from Investing Activities was -$2.1 million for Q2 2026 at Repligen, up from -$4.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $64.8 million in Q2 2023 and troughed at -$208.7 million in Q4 2025.
  • A 5-year average of -$41.5 million and a median of -$9.1 million in 2023 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities jumped 347.27% in 2023 and slumped 786.25% in 2025, its largest moves.
  • Over 5 years, Cash from Investing Activities stood at -$121.3 million in 2022, then slumped by 40.06% to -$169.9 million in 2023, then soared by 61.88% to -$64.8 million in 2024, then sank by 222.32% to -$208.7 million in 2025, then soared by 99.0% to -$2.1 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$2.1 million (Q2 2026), -$4.0 million (Q1 2026), and -$208.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 164.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -10.15 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -1.03 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -122.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -3.51 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -7.06 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -66.70 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -2.09 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -7.74 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -25.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.09 Mn
Mar 31, 2026 -3.99 Mn
Dec 31, 2025 -208.74 Mn
Sep 30, 2025 -7.78 Mn
Jun 30, 2025 -7.84 Mn
Mar 31, 2025 -74.11 Mn
Dec 31, 2024 -64.76 Mn
Sep 30, 2024 -5.86 Mn
Jun 30, 2024 -7.40 Mn
Mar 31, 2024 -8.36 Mn
Dec 31, 2023 -169.91 Mn
Sep 30, 2023 -8.77 Mn
Jun 30, 2023 64.83 Mn
Mar 31, 2023 -9.43 Mn
Dec 31, 2022 -121.31 Mn
Sep 30, 2022 -57.49 Mn
Jun 30, 2022 -26.22 Mn
Mar 31, 2022 -28.21 Mn
Dec 31, 2021 -62.28 Mn
Sep 30, 2021 -132.70 Mn